A blockade of the RRM1 gene results in the upregulation of DNA damage response genes and p53-regulated genes, thereby inhibiting the growth and promoting apoptosis of myeloma cells and cells of the bone marrow microenvironment [59]. Here, TP53 is linked to plasma cell myeloma.